Headtohead trial shows Eli Lilly’s oral GLP1 orforglipron outperforms oral semaglutide
Feb 26, 2026
A new trial found that Eli Lilly’s GLP-1 pill resulted in greater reductions in blood sugar levels and weight than oral semaglutide did, but fewer people stayed on it
https://www.scientificamerican.com/article/head-to-head-trial-shows-eli-lillys-oral-glp-1-orforglipron-outperforms-oral/
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service